There are many misconceptions about cannabis use, and a team of British and Australian researchers recently demystified one of them. Based on the findings of a study published on Nov. 16, 2022, in the journal Neuropsychopharmacology, inhaling cannabidiol (CBD) with tetrahydrocannabinol (THC) did not shield study subjects from the short-term effects of a THC “high.”
Some research has indicated that CBD may relieve some negative side effects associated with delta-9 THC, including delusions, hallucinations, and memory/attention changes. However, a growing body of research has found no direct impact of CBD on the effects of THC.
Researchers failed to dig up any proof that CBD decreases the enjoyable or negative effects of THC. Conversely, separate research has hypothesized that CBD may mitigate the mind-altering effects of THC. Researchers tested various ratios of CBD to THC to determine how the two cannabinoids react inside the body after inhalation.
To paint a clearer picture of CBD’s influence on THC consumption, large-scale studies must be carried out in the future. In 2020, cannabis consumers around the world spent $415 billion on THC-rich products. The global CBD oil market, on the other hand, is predicted to inflate from $967.2 million in 2020 to $5.3 billion in 2025.
Researchers recruited 46 healthy volunteers between the ages of 21 and 50 years old for the study. Each study subject had previously used cannabis, but not more than once weekly during the past year. Four experiments were conducted, with each involving cannabis vapor inhalation. Participants consumed vaporizable cannabis with 10 milligrams of THC blended with varying levels of CBD (0 mg, 10 mg, 20 mg, or 30 mg).
According to study author Amir Englund, Ph.D., a research fellow at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience, the aforementioned CBD-to-THC ratios were selected because they represent the most common types of cannabis products used for recreational purposes.
Once cannabis was used, participants engaged in a number of tasks to assess the temporary effects of THC and CBD on cognitive performance. Additionally, the study subjects were assessed on their level of pleasure. “Psychotic symptoms”, including conceptual disorganization, delusions, grandiosity, hallucinations, hostility, hyperactivity, and suspiciousness, were also measured by the researchers.
Following CBD and THC inhalation, study subjects experienced the short-term impacts of THC. Additionally, researchers found that THC consumption amplified pleasure levels when the THC was consumed while indulging in chocolate and listening to music. One of the key takeaways from the study was that participants coughed more as they consumed higher levels of CBD.
The study into CBD’s impact on THC consumption was limited by the fact that no placebo condition was included. Had a placebo condition been included, study subjects would have inhaled vapor without THC or CBD—a technique that would have enabled researchers to compare the effects of vapor inhalation with the consumption of THC alone.
“Like much psychedelic research, placebo comparisons become difficult because the vast majority of people will be relatively certain if they’ve had the drug or not since the intoxication is quite pronounced,” said Englund, who noted that he and his colleagues are interested in carrying out future studies to pinpoint what THC dosages spark side effects such as anxiety, memory problems, and paranoia. “This will give users practical information about how to avoid unwanted effects,” he added.
After reviewing the study results, the director of the UCI Center for the Study of Cannabis in Irvine, CA, Daniele Piomelli, told reporters at Healthline that the study was well executed. However, he disagreed with the researchers’ classification of THC’s effects as “psychotic.”
“There is no evidence that if you and I were to smoke pot that we would be psychotic. We would be high. We would be stoned. But we would not be psychotic,” he stated.
On the other hand, he drew attention to the fact that there is proof of adolescent cannabis use—especially high-dose consumption—increasing the risk of psychotic episodes occurring later on in life. However, this differs from the short-term effects experienced by the majority of cannabis consumers.
“Cannabis has certain effects. Some people may like them, some people may not,” Piomelli said. “As long as you’re not harming other people or making your own life problematic, I don’t think we should say that you’re experiencing psychosis.”
His views are shared by many researchers, with a 2016 study titled, “Cannabis and Psychosis: a Critical Overview of the Relationship” highlighting evidence that “cannabis does not in itself cause a psychosis disorder.” Further research is required to determine the combined effects of CBD and THC.
Consuming alcohol heavily in young adulthood is associated with an increased likelihood of developing alcohol use disorder (AUD), the most widespread substance-related disorder worldwide. Research has already shed light on the effects of individual differences like alcohol sensitivity and cardiovascular responses in predicting binge drinking behaviors and progression to AUD. However, there remains a gap…
Kentucky is once again exploring medical cannabis legalization, D.C. made good on its expungement promises, and Minnesota okayed a psychedelic task force. Let’s dive into this week’s cannanews. Kentucky Inches Toward Medical Cannabis Legalization Earlier this week, Kentucky’s State Senate passed a new proposal that seeks to legalize medical cannabis in the state. Under the…
The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. On Tuesday, January 24, several legislative bills were unveiled by the Japanese government. One of the proposed bills would amend the Cannabis Control Law…
Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. One psychedelic that’s been getting a whole lot of attention lately is psilocybin, an active ingredient in mushroom species that are often called “magic mushrooms.” Psilocybin is a naturally…
Missouri is home to an estimated population of roughly 6 million residents. The state is popular for the agriculture industry, barbecue, and historic landmarks like the Gateway Arch. Missouri borders eight states and is a gateway to adventure in the land of legal cannabis. Six of the eight states surrounding Missouri have very strict cannabis…
At one time, there was a sign coming into Las Vegas that read, “Don’t gamble with marijuana.” In Nevada, possession equals 20…
Maryland and Delaware are exploring their cannabis policies, a Texas representative introduced another decriminalization bill, and New Orleans okayed cannabis-infused seltzers. Let’s…
Who would have thought that cannabis cultivation could be Alaska’s biggest earner? Over the course of the next eight years, marijuana cultivation…